ACE2 and infection: This suggests that A19-46.1, A23-58.1, and B1-182.1 neutralize infection by directly blocking the interaction of RBD with ACE2 and would be classified as either class I (ACE2 blocking, binding RBD up only) or II (ACE2 blocking, binding RBD up or down) RBD antibodies (18).